Greengard O
Pediatr Res. 1977 May;11(5):669-76. doi: 10.1203/00006450-197705000-00009.
The quantitative pattern of enzymes in the second trimester human fetal liver is significantly different from that of adult liver. For some 20 enzymes, the activity quotient (AQ, i.e., activity of immature liver divided by that in adult liver) is appreciably different from 1.0. Most of the enzymes increase their concentrations with age but, as one would expect, some contribute to differentiation by diminishing in amount. In developing human liver the concentrations of the various enzymes tend to change in the same direction as they do in rat liver. Those that increase in rat liver have been classified into three main clusters, according to whether their rise begins on about the 17th day of gestation (B), the first neonatal day (C), or just before weaning (D), respectively. The distribution of these enzymes among these three clusters correlates with their AQ's in the human fetal liver. In general, enzymes with AQ around 0.5 belong to cluster (B) in rat liver whereas those with 0-0.16 belong to cluster C or D. Gross malformations resulting from the teratogenic action of drugs, hormones, or vitamins on the early embryo attract much attention. The harmful impacts of such agents at late stages of gestation are less spectacular. They may be more frequent, however, and manifest themselves in permanent inadequacies in metabolism or growth with a tendency to succumb to minor childhood diseases. The underlying causes may not be mirrored in the cytocomposition or even the subcellular morphology of autopsy specimens. Only deviations from the organ characteristic quantitative pattern of gene products would provide sensitive enough indictors of the metabolic lesions and of the aberrant aspects of differentiation that were responsible for them. In both the presence and absence of detectable morphologic abnormalities, the study of enzymes, this most varied and largest class of specific chemical constituents, would greatly extend the resolving power of the usual diagnostic procedures postmortem.
孕中期人类胎儿肝脏中酶的定量模式与成人肝脏显著不同。对于约20种酶而言,活性商(AQ,即未成熟肝脏的活性除以成人肝脏的活性)明显不同于1.0。大多数酶的浓度随年龄增加,但正如人们所预期的,有些酶通过减少量来促进分化。在发育中的人类肝脏中,各种酶的浓度变化趋势与大鼠肝脏相同。根据其升高分别始于妊娠第17天左右(B组)、出生第一天(C组)还是断奶前(D组),大鼠肝脏中升高的那些酶已被分为三个主要类别。这些酶在这三个类别中的分布与它们在人类胎儿肝脏中的AQ相关。一般来说,AQ约为0.5的酶属于大鼠肝脏中的B组,而AQ为0 - 0.16的酶属于C组或D组。药物、激素或维生素对早期胚胎的致畸作用导致的严重畸形备受关注。此类因素在妊娠后期的有害影响则不那么显著。然而,它们可能更频繁,并表现为代谢或生长方面的永久性缺陷,且易患小儿轻症。潜在原因可能无法在尸检标本的细胞组成甚至亚细胞形态中体现出来。只有基因产物的器官特征性定量模式出现偏差,才能提供足够敏感的指标,用以指示代谢损伤以及导致这些损伤的分化异常方面。无论是否存在可检测到的形态学异常,对酶(这一最多样化且最大类别的特定化学成分)的研究都将极大地扩展常规尸检诊断程序的分辨能力。